What the Study Found (In Plain English)
Published in CPT: pharmacometrics & systems pharmacology (2021), this phase iii randomized trial evaluating human clinical outcomes investigated: Pediatric extrapolation is essential for bringing treatments to the pediatric population, especially for indications where the recruitment of pediatric patients into clinical trials is difficult and where fully powered trials are impossible. Key clinical takeaway: Only after accounting for this difference an apparent mismatch between the extrapolation from adults and the pediatric study could be resolved.
Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers
Primary Endpoint & Quantitative Summary (CPT: pharmacometrics & systems pharmacology, 2021-06-15; Phase III Randomized Trial; Rigor 82/100): Only after accounting for this difference an apparent mismatch between the extrapolation from adults and the pediatric study could be resolved.
Study Limitations & Caveats Before You Act
Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Phase III Randomized Trial). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.